title: Different clinical value of minimal residual disease after autologous and allogenic stem cell transplantation for chronic lymphocytic leukemia.
authors.forename: Jordi
authors.initials: J
authors.lastname: Esteve
authors.forename: Neus
authors.initials: N
authors.lastname: Villamor
authors.forename: Dolors
authors.initials: D
authors.lastname: Colomer
authors.forename: Emil
authors.initials: E
authors.lastname: Montserrat
mesh_terms: D018450:Disease Progression; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome